Evidence map›Paper›PMID 40038615›Full record

ArticleBMC infectious diseases2025

The origin and dissemination of HIV-1 subtype B on Hainan Island, South China, 2007-2024.

Chunyun Lu, Kaokao Zhu, Nengde Zhang, Mu Li, Shanmei Zhong, Cai Qin, Tong Luo, Rongjing Zhang, Jing Zhang, Yi Ning and 4 more

Erratum issuedAbstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Chunyun Lu *School of Public Health, Heinz Mehlhorn Academician Workstation, Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University, Haikou, Hainan, 571199, China.
Kaokao Zhu *The Fifth People's Hospital of Hainan Province, Affiliated Dermatology Hospital of Hainan Medical University, Haikou, Hainan, 570102, China.
Nengde Zhang *School of Public Health, Heinz Mehlhorn Academician Workstation, Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University, Haikou, Hainan, 571199, China.
Mu LiGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, China.
Shanmei ZhongGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, China.
Cai QinGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, China.
Tong LuoGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, China.
Rongjing ZhangGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, China.
Jing ZhangSchool of Public Health, Heinz Mehlhorn Academician Workstation, Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University, Haikou, Hainan, 571199, China.
Yi NingSchool of Public Health, Heinz Mehlhorn Academician Workstation, Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University, Haikou, Hainan, 571199, China.
Hao LiangCollaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, 530021, China.
Li YeCollaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, 530021, China. yeli@gxmu.edu.cn.
Bingyu LiangGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, China. liangbingyu@gxmu.edu.cn.
Dee YuSchool of Public Health, Heinz Mehlhorn Academician Workstation, Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University, Haikou, Hainan, 571199, China. yudee@muhn.edu.cn.

Funding

Hainan Provincial Natural Science Foundation of China 824RC519postgraduate innovation program of Hainan Medical University HYYS2022B13
6 · The paper itself

Abstract

backgroundHIV-1 subtype B, introduced to mainland China at an early stage, rapidly spread among commercial plasma donors and heterosexuals (HETs) during the 1990s. It was first identified in Hainan, which has a population of 10 million, in 2007. Nevertheless, there is a paucity of data about the molecular-epidemiological characteristics, spatial origins, and transmission patterns of this strain on the island of China.

methodsPol sequences for HIV-1 subtype B from Hainan Island (2007-2024) were obtained from our research and global databases. An analysis of phylogenetic data, molecular clock models, and a Bayesian coalescent-based approach was performed to investigate how HIV-1 subtype B was introduced and disseminated on this island.

resultsA total of 76 sequences were obtained from Hainan Island, of which 52.63% were collected from men who have sex with men (MSM). Phylogenetic analysis demonstrated that HIV-1 subtype B circulating on the island was closely related to HIV-1 sequence lineages in Guangdong (22.84%, 127/556), Hubei (12.59%, 70/556), and Beijing (14.03%, 78/556), indicating multiple introductions from various cities in China. Bayesian time-scaled phylogenetic reconstructions revealed that 27 Hainan sequences were together in clusters [posterior probability (PP) > 0.90], and 18 Hainan sequences were intermixed in larger clades containing sequences from other provinces (PP > 0.90). Bayes factors (BF) demonstrated that subtype B on the Island originated from Guangdong Province (BF > 100) in 1999.9 (95% HPD:1996.7, 2002.7) and Hubei Province (BF > 100) in 2007.9 (95% HPD:2004.4, 2011.2). Subsequently, HIV-1 subtype B was introduced to Beijing from the island (BF > 100). The analysis of viral migration patterns among risk subgroups revealed that subtype B was introduced to the island by MSMs (BF > 100). Within the island, this strain was from MSM to HETs (BF > 100).

conclusionUsing Hainan Island as a case study, our findings shed light on the intricate evolution and transmission dynamics of HIV-1 subtype B on the island, revealing crucial insights for HIV prevention efforts in the future.

Indexed as

HIV-1HIV InfectionsAdultBayes TheoremChinaFemaleGenotypeHomosexuality, MaleHumansIslandsMaleMolecular EpidemiologyPhylogenyHainan IslandHIV-1OriginPhylogenetic analysisSubtype B

Identifiers

PMID40038615
PMCPMC11877774

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.